OTCMKTS:PFSCF - ProMetic Life Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0350 0.00 (0.00 %) (As of 05/19/2019 04:00 PM ET)Previous Close$0.0350Today's Range$0.0320 - $0.0452-Week Range$0.0268 - $0.75Volume233,105 shsAverage Volume246,439 shsMarket Capitalization$25.87 millionP/E RatioN/ADividend YieldN/ABeta3.04 ProfileAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada. Receive PFSCF News and Ratings via Email Sign-up to receive the latest news and ratings for PFSCF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PFSCF Previous SymbolNASDAQ:PFSCF CUSIPN/A CIKN/A Webwww.prometic.com Phone1-450-781-0115Debt Debt-to-Equity Ratio2.38 Current Ratio1.14 Quick Ratio0.81Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$36.55 million Price / Sales0.71 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-0.50Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-150,730,000.00 Net Margins-373.05% Return on Equity-239.72% Return on Assets-34.26%Miscellaneous Employees487 Outstanding Shares739,130,000Market Cap$25.87 million Next Earnings Date8/13/2019 (Estimated) OptionableNot Optionable ProMetic Life Sciences (OTCMKTS:PFSCF) Frequently Asked Questions What is ProMetic Life Sciences' stock symbol? ProMetic Life Sciences trades on the OTCMKTS under the ticker symbol "PFSCF." How were ProMetic Life Sciences' earnings last quarter? ProMetic Life Sciences Inc. (OTCMKTS:PFSCF) released its quarterly earnings data on Monday, April, 1st. The company reported $0.01 earnings per share for the quarter. The firm earned $8.02 million during the quarter. ProMetic Life Sciences had a negative net margin of 373.05% and a negative return on equity of 239.72%. View ProMetic Life Sciences' Earnings History. When is ProMetic Life Sciences' next earnings date? ProMetic Life Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for ProMetic Life Sciences. What is the consensus analysts' recommendation for ProMetic Life Sciences? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProMetic Life Sciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ProMetic Life Sciences. Has ProMetic Life Sciences been receiving favorable news coverage? News coverage about PFSCF stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ProMetic Life Sciences earned a news impact score of 1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term. Who are some of ProMetic Life Sciences' key competitors? Some companies that are related to ProMetic Life Sciences include Unum Therapeutics (UMRX), Catalyst Biosciences (CBIO), Cumberland Pharmaceuticals (CPIX), Correvio Pharma (CORV), Selecta Biosciences (SELB), Vernalis (VNLPY), Iterum Therapeutics (ITRM), China SXT Pharmaceuticals (SXTC), Zafgen (ZFGN), Processa Pharmaceuticals (PCSA), Catabasis Pharmaceuticals (CATB), Neurotrope (NTRP), Adamis Pharmaceuticals (ADMP), Entasis Therapeutics (ETTX) and Otonomy (OTIC). What other stocks do shareholders of ProMetic Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProMetic Life Sciences investors own include ProMetic Life Sciences (PLI), Inovio Pharmaceuticals (INO), Protalix Biotherapeutics (PLX), ADMA Biologics (ADMA), Allena Pharmaceuticals (ALNA), Cerecor (CERC), Corbus Pharmaceuticals (CRBP), Gemphire Therapeutics (GEMP), Genocea Biosciences (GNCA) and Novavax (NVAX). Who are ProMetic Life Sciences' key executives? ProMetic Life Sciences' management team includes the folowing people: Mr. Kenneth H. Galbraith, CEO & Director (Age 56)Mr. Bruce Pritchard, COO & Interim CFOMr. Patrick Sartore, Chief Legal Officer & Corp. Sec.Mr. Bruce Wendel, Chief Bus. Devel. Officer (Age 65)Dr. John Moran, Chief Medical Officer (Age 73) How do I buy shares of ProMetic Life Sciences? Shares of PFSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ProMetic Life Sciences' stock price today? One share of PFSCF stock can currently be purchased for approximately $0.0350. How big of a company is ProMetic Life Sciences? ProMetic Life Sciences has a market capitalization of $25.87 million and generates $36.55 million in revenue each year. ProMetic Life Sciences employs 487 workers across the globe. What is ProMetic Life Sciences' official website? The official website for ProMetic Life Sciences is http://www.prometic.com. How can I contact ProMetic Life Sciences? ProMetic Life Sciences' mailing address is 440 Boulevard Armand-Frappier Suite 300, Laval A8, H7V 4B4. The company can be reached via phone at 1-450-781-0115 or via email at [email protected] MarketBeat Community Rating for ProMetic Life Sciences (OTCMKTS PFSCF)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 84 (Vote Outperform)Underperform Votes: 99 (Vote Underperform)Total Votes: 183MarketBeat's community ratings are surveys of what our community members think about ProMetic Life Sciences and other stocks. Vote "Outperform" if you believe PFSCF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PFSCF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: The role of implied volatility with call option volume Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.